Dynogen Pharmaceuticals' Series A Round

Dynogen Pharmaceuticals raised a round of funding on November 19, 2002.

Dynogen is a biopharmaceutical company developing drugs for gastrointestinal (GI) and genitourinary (GU) disorders, including irritable bowel syndrome (IBS) and overactive bladder (OAB). Dynogen focus…

Articles about Dynogen Pharmaceuticals' Series A Round: